ArticleBMC medical genomics2026
Elucidating the mechanisms of bisphenols-induced male spermatogenesis disorder via network toxicology, molecular docking and bioinformatics.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bisphenols (BPs), are extensively utilized in various manufacturing industries, leading to increased human exposure and detection in diverse environments, posing potential risks to reproductive health. This study endeavors to investigate whether seven BP compounds result in male spermatogenesis disorder (SD) and explore the underlying molecular mechanisms involved. Network toxicology was integrated with molecular docking technology and bioinformatics data to systematically elucidate the roles, underlying targets and pathological mechanisms of each BP compound in the SD process. Network toxicology analysis revealed that all seven BPs induced SD through similar mechanisms. The protein-protein interaction (PPI) network identified key targets implicated in SD induced by each BP, while enrichment analysis highlighted that BPs primarily affected SD through hormone-dependent pathways, cell proliferation, apoptosis, and prostate cancer pathways. Molecular docking further confirmed the pivotal role of these targets in BPs-induced SD. Additionally, analysis of Gene Expression Omnibus (GEO) data demonstrated significant differential expression of these genes in the SD patients compared to normal controls. These results underscored the crucial effects of genes such as BCL2, PARP1, AKT1, EGFR, ESR1, ESR2, HIF1A, HSP90AA1 and GSK3B in the development of SD. Collectively, these findings indicated that BPs exposure could contribute to the onset of SD as an environmental trigger, while offering theoretical insights into the molecular mechanisms associated with BPs-elicited SD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.